查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1269398

医疗用食品市场(产品类型:锭剂，粉末，液体，其他，给药途径:口服，佛经肠)-全球产业分析，规模，占有率，成长，趋势，预测，2023年-2031年

Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 232 Pages | 商品交期: 2-10个工作天内

价格

医疗用食品市场- 调查范围:

TMR 的研究报告《全球医疗用食品市场》为了提供2023年～2031年预测期间上关于市场指标的宝贵知识和见解，不仅探讨了过去的增长趋势，还调查了当前的增长趋势和机会。本报告以 2023 年为基准年，2031 年为预测年。提供2017年到2031年的全球医疗用食品市场收益。并刊载2023年2031年的全球医疗用食品市场年复合成长率。

本报告透过广泛研究作成。初步研究中由分析师对主要意见领袖、行业领袖和舆论製造者进行访谈，并进行大部分研究工作。二次研究则参考主要公司的产品资料、年报、新闻稿和相关文件，来掌握医疗用食品市场。

该报告深入探讨全球医疗用食品市场的竞争格局。锁定全球医疗用食品市场活动的主要企业，并对每家公司进行了不同属性的分析。介绍企业概要，财务状况，最近的趋势，SWOT等全球医疗用食品市场企业的属性。

目录

第1章 序文

  • 市场定义和范围
  • 市场区隔
  • 主要的调查目的
  • 调查亮点

第2章 前提条件与调查手法

第3章 摘要整理:全球市场

第4章 市场概要

  • 简介
  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会

第5章 主要洞察

  • 新兴国家市场趋势
  • 市场进入的前3名企业
  • 有市场竞争力的新加入企业
  • 医疗用食品法规概要
  • 保险偿付方案
  • 各种疾病的流通管道概要和那个外壳

第6章 全球市场分析·预测:各产品类型

  • 简介和定义
  • 主要调查结果/开发情形
  • 市场价值预测:各产品类型，2017-2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场魅力分析:各产品类型

第7章 全球市场分析·预测:各疾病类型

  • 简介和定义
  • 主要调查结果/发展情形
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场魅力分析:各疾病类型

第8章 全球市场分析·预测:各给药途径

  • 简介和定义
  • 主要调查结果/发展情形
  • 市场价值预测:各给药途径，2017年～2031年
    • 口服
    • 佛经肠
  • 市场魅力分析:各给药途径

第9章 全球市场分析·预测:各流通管道

  • 简介和定义
  • 主要调查结果/发展情形
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场魅力分析:各流通管道

第10章 全球市场分析·预测:各地区

  • 主要调查结果
  • 市场规模预测:各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东·非洲地区
  • 市场魅力分析:各地区

第11章 北美市场分析·预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各产品类型，2017-2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场价值预测:各给药途径，2017-2031年
    • 口服
    • 佛经肠
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场价值预测:各国，2017-2031年
    • 美国
    • 加拿大
  • 市场魅力分析
    • 各产品
    • 各疾病类型
    • 各给药途径
    • 各销售管道
    • 各国

第12章 欧洲市场分析与预测

  • 简介
    • 主要的调查结果
  • 市场价值预测:各产品类型，2017-2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场价值预测:各给药途径，2017-2031年
    • 口服
    • 佛经肠
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场价值预测:国家·小各地区，2017-2031年
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 市场魅力分析
    • 各产品类型
    • 各疾病类型
    • 各给药途径
    • 各销售管道
    • 各国/子地区

第13章 亚太地区的市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各产品类型，2017-2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场价值预测:各给药途径，2017-2031年
    • 口服剂
    • 佛经肠
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场价值预测:国家·小各地区，2017-2031年
    • 中国
    • 日本
    • 印度
    • 澳洲·纽西兰
    • 其他亚太地区
  • 市场魅力分析
    • 各产品类型
    • 各疾病类型
    • 各给药途径
    • 各销售管道
    • 各国/子地区

第14章 南美的市场分析·预测

  • 简介
    • 主要的调查结果
  • 市场价值预测:各产品类型，2017年～2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场价值预测:各给药途径，2017-2031年
    • 口服剂
    • 佛经肠
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场价值预测:国家·小各地区，2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美国家地区
  • 市场魅力分析
    • 各产品类型
    • 各疾病类型
    • 各给药途径
    • 各销售管道
    • 各国/子地区

第15章 中东·非洲市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各产品类型，2017年～2031年
    • 锭剂
    • 粉末
    • 液体
    • 其他
  • 市场价值预测:各疾病类型，2017-2031年
    • 孤儿病
      • 裘馨氏肌肉萎缩症(DMD)
      • 镰状细胞贫血症
      • 血友病
      • 其他
    • 癌症
    • 神经·精神疾病
    • 代谢性疾病
    • 疼痛管理
    • 消化器官系统疾病
    • 眼科领域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癫痫
  • 市场价值预测:各给药途径，2017-2031年
    • 口服
    • 佛经肠
  • 市场价值预测:各流通管道，2017-2031年
    • 药局·药妆店
    • 线上流通管道
    • 超级市场&大卖场
    • 其他
  • 市场价值预测:国家·小各地区，2017-2031年
    • GCC各国
    • 南非
    • 其他中东·非洲
  • 市场魅力分析
    • 各产品类型
    • 各疾病类型
    • 各给药途径
    • 各销售管道
    • 各国/子地区

第16章 竞争情形

  • 市场竞争-竞争矩阵(企业各层级，不同企业规模)
  • 竞争的商务策略
  • 企业简介
    • Nutricia(Danone)
    • Nestle S.A.
    • Abbott Laboratories
    • Mead Johnson Nutrition
    • Fresenius Kabi
    • Friso
    • Morinaga Milk Industry
    • Primus Pharmaceuticals, Inc.
    • Targeted Medical Pharma, Inc.
    • Medtrition, Inc.
Product Code: TMRGL45447

Medical Foods Market - Scope of Report:

TMR's report on the global medical foods market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global medical foods market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical foods market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical foods market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical foods market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical foods market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical foods market.

The report delves into the competitive landscape of the global medical foods market. Key players operating in the global medical foods market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical foods market profiled in this report.

Key Questions Answered in Global Medical Foods Market Report:

  • What is the sales/revenue generated by medical foods across all regions during the forecast period?
  • What are the opportunities in the global medical foods market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Medical Foods Market - Research Objectives and Research Approach:

The comprehensive report on the global medical foods market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical foods market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical foods market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Foods Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities

5. Key Insights

  • 5.1. Important market developments
  • 5.2. Top 3 Players Operating in the Market Space
  • 5.3. New competitive market entrants
  • 5.4. Medical food regulation overview
  • 5.5. Reimbursement Scenario
  • 5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples

6. Global Medical Foods Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Pills
    • 6.3.2. Powder
    • 6.3.3. Liquid
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Medical Foods Market Analysis and Forecast, by Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Type, 2017-2031
    • 7.3.1. Orphan Disease
      • 7.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 7.3.1.2. Sickle Cell Anemia
      • 7.3.1.3. Hemophilia
      • 7.3.1.4. Others
    • 7.3.2. Cancer
    • 7.3.3. Neurological & Psychological Disorders
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Pain Management
    • 7.3.6. Gastrointestinal Disorders
    • 7.3.7. Ophthalmology
    • 7.3.8. Diabetes
    • 7.3.9. Phenylketonuria (PKU)
    • 7.3.10. Epilepsy
  • 7.4. Market Attractiveness Analysis, by Disease Type

8. Global Medical Foods Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Oral
    • 8.3.2. Enteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Pharmacies & Drug Stores
    • 9.3.2. Online Channels
    • 9.3.3. Supermarkets & Hypermarkets
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Medical Foods Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Medical Foods Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Pills
    • 11.2.2. Powder
    • 11.2.3. Liquid
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Disease Type, 2017-2031
    • 11.3.1. Orphan Disease
      • 11.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 11.3.1.2. Sickle Cell Anemia
      • 11.3.1.3. Hemophilia
      • 11.3.1.4. Others
    • 11.3.2. Cancer
    • 11.3.3. Neurological & Psychological Disorders
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Pain Management
    • 11.3.6. Gastrointestinal Disorders
    • 11.3.7. Ophthalmology
    • 11.3.8. Diabetes
    • 11.3.9. Phenylketonuria (PKU)
    • 11.3.10. Epilepsy
  • 11.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 11.4.1. Oral
    • 11.4.2. Enteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Pharmacies & Drug Stores
    • 11.5.2. Online Channels
    • 11.5.3. Supermarkets & Hypermarkets
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Disease Type
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Medical Foods Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Pills
    • 12.2.2. Powder
    • 12.2.3. Liquid
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Disease Type, 2017-2031
    • 12.3.1. Orphan Disease
      • 12.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 12.3.1.2. Sickle Cell Anemia
      • 12.3.1.3. Hemophilia
      • 12.3.1.4. Others
    • 12.3.2. Cancer
    • 12.3.3. Neurological & Psychological Disorders
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Pain Management
    • 12.3.6. Gastrointestinal Disorders
    • 12.3.7. Ophthalmology
    • 12.3.8. Diabetes
    • 12.3.9. Phenylketonuria (PKU)
    • 12.3.10. Epilepsy
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Oral
    • 12.4.2. Enteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Pharmacies & Drug Stores
    • 12.5.2. Online Channels
    • 12.5.3. Supermarkets & Hypermarkets
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. by Product Type
    • 12.7.2. By Disease Type
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Medical Foods Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Pills
    • 13.2.2. Powder
    • 13.2.3. Liquid
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Disease Type, 2017-2031
    • 13.3.1. Orphan Disease
      • 13.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 13.3.1.2. Sickle Cell Anemia
      • 13.3.1.3. Hemophilia
      • 13.3.1.4. Others
    • 13.3.2. Cancer
    • 13.3.3. Neurological & Psychological Disorders
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Pain Management
    • 13.3.6. Gastrointestinal Disorders
    • 13.3.7. Ophthalmology
    • 13.3.8. Diabetes
    • 13.3.9. Phenylketonuria (PKU)
    • 13.3.10. Epilepsy
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Oral
    • 13.4.2. Enteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Pharmacies & Drug Stores
    • 13.5.2. Online Channels
    • 13.5.3. Supermarkets & Hypermarkets
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. by Product Type
    • 13.7.2. By Disease Type
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Medical Foods Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Pills
    • 14.2.2. Powder
    • 14.2.3. Liquid
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Disease Type, 2017-2031
    • 14.3.1. Orphan Disease
      • 14.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 14.3.1.2. Sickle Cell Anemia
      • 14.3.1.3. Hemophilia
      • 14.3.1.4. Others
    • 14.3.2. Cancer
    • 14.3.3. Neurological & Psychological Disorders
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Pain Management
    • 14.3.6. Gastrointestinal Disorders
    • 14.3.7. Ophthalmology
    • 14.3.8. Diabetes
    • 14.3.9. Phenylketonuria (PKU)
    • 14.3.10. Epilepsy
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Oral
    • 14.4.2. Enteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Pharmacies & Drug Stores
    • 14.5.2. Online Channels
    • 14.5.3. Supermarkets & Hypermarkets
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. by Product Type
    • 14.7.2. By Disease Type
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Medical Foods Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. Pills
    • 15.2.2. Powder
    • 15.2.3. Liquid
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Disease Type, 2017-2031
    • 15.3.1. Orphan Disease
      • 15.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 15.3.1.2. Sickle Cell Anemia
      • 15.3.1.3. Hemophilia
      • 15.3.1.4. Others
    • 15.3.2. Cancer
    • 15.3.3. Neurological & Psychological Disorders
    • 15.3.4. Metabolic Disorders
    • 15.3.5. Pain Management
    • 15.3.6. Gastrointestinal Disorders
    • 15.3.7. Ophthalmology
    • 15.3.8. Diabetes
    • 15.3.9. Phenylketonuria (PKU)
    • 15.3.10. Epilepsy
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Oral
    • 15.4.2. Enteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.5.1. Pharmacies & Drug Stores
    • 15.5.2. Online Channels
    • 15.5.3. Supermarkets & Hypermarkets
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. by Product Type
    • 15.7.2. By Disease Type
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Competitive Business Strategies
  • 16.3. Company Profiles
    • 16.3.1. Nutricia (Danone)
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Nestle S.A.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Mead Johnson Nutrition
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Fresenius Kabi
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Friso
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Morinaga Milk Industry
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Primus Pharmaceuticals, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Targeted Medical Pharma, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Medtrition, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 02: Global Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 03: Global Medical Foods Market Revenue (US$ Mn), by Pills, 2017-2031
  • Figure 04: Global Medical Foods Market Revenue (US$ Mn), by Powder, 2017-2031
  • Figure 05: Global Medical Foods Market Revenue (US$ Mn), by Liquid, 2017-2031
  • Figure 06: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 07: Global Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 08: Global Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 09: Global Medical Foods Market Revenue (US$ Mn), by Orphan Disease, 2017-2031
  • Figure 10: Global Medical Foods Market Revenue (US$ Mn), by Cancer, 2017-2031
  • Figure 11: Global Medical Foods Market Revenue (US$ Mn), by Neurological & Psychological Disorders, 2017-2031
  • Figure 12: Global Medical Foods Market Revenue (US$ Mn), by Metabolic Disorders, 2017-2031
  • Figure 13: Global Medical Foods Market Revenue (US$ Mn), by Pain Management, 2017-2031
  • Figure 14: Global Medical Foods Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2017-2031
  • Figure 15: Global Medical Foods Market Revenue (US$ Mn), by Ophthalmology, 2017-2031
  • Figure 16 Global Medical Foods Market Revenue (US$ Mn), by Diabetes, 2017-2031
  • Figure 17: Global Medical Foods Market Revenue (US$ Mn), by Phenylketonuria (PKU), 2017-2031
  • Figure 18: Global Medical Foods Market Revenue (US$ Mn), by Epilepsy, 2017-2031
  • Figure 19: Global Medical Foods Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 20: Global Medical Foods Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 21: Global Medical Foods Market Revenue (US$ Mn), by Oral, 2017-2031
  • Figure 22: Global Medical Foods Market Revenue (US$ Mn), by Enteral, 2017-2031
  • Figure 23: Global Medical Foods Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 24: Global Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 25: Global Medical Foods Market Revenue (US$ Mn), by Pharmacies & Drug Stores, 2017-2031
  • Figure 26: Global Medical Foods Market Revenue (US$ Mn), by Online Channels, 2017-2031
  • Figure 27: Global Medical Foods Market Revenue (US$ Mn), by Supermarkets & Hypermarkets, 2017-2031
  • Figure 28: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 29: Global Medical Foods Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 30: Global Medical Foods Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 31: North America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: North America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 33: North America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 34: North America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 35 North America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 36: North America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 37: North America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 38: North America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39: North America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Europe Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 41: Europe Medical Foods Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Medical Foods Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Europe Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 44: Europe Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 45: Europe Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 46: Europe Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 47: Europe Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 48: Europe Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 49: Europe Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 50: Europe Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 51: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: Asia Pacific Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 53: Asia Pacific Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 54: Asia Pacific Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 55: Asia Pacific Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 56: Asia Pacific Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 57: Asia Pacific Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 58: Asia Pacific Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 59: Asia Pacific Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 60: Latin America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 61: Latin America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 62: Latin America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 63: Latin America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 64: Latin America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 65: Latin America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 66: Latin America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 67: Latin America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 68: Latin America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 69: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 70: Middle East and Africa Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 71: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 72: Middle East and Africa Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 73: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 74: Middle East and Africa Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 75: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 76: Middle East and Africa Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 77: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031